Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (24540) 24540
Newsletter (2321) 2321
Publication (2297) 2297
Book Review (251) 251
Book Chapter (142) 142
Newspaper Article (93) 93
Conference Proceeding (64) 64
Book / eBook (51) 51
Dissertation (42) 42
Web Resource (15) 15
Magazine Article (10) 10
Journal / eJournal (5) 5
Transcript (4) 4
Reference (3) 3
Data Set (2) 2
Presentation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16768) 16768
index medicus (11927) 11927
gliomas (11286) 11286
oncology (9996) 9996
male (8495) 8495
female (8223) 8223
glioma (7525) 7525
radiotherapy (6951) 6951
cancer (6667) 6667
adult (6196) 6196
glioblastoma (6169) 6169
middle aged (6076) 6076
clinical neurology (5833) 5833
brain neoplasms - pathology (5071) 5071
chemotherapy (5004) 5004
tumors (4940) 4940
brain tumors (4657) 4657
aged (4559) 4559
animals (4144) 4144
glioma - pathology (3968) 3968
surgery (3783) 3783
care and treatment (3646) 3646
prognosis (3596) 3596
research (3501) 3501
medicine & public health (3365) 3365
glioblastoma multiforme (3275) 3275
brain neoplasms - radiotherapy (3263) 3263
survival (3248) 3248
brain neoplasms - drug therapy (3115) 3115
temozolomide (3079) 3079
cell line, tumor (2987) 2987
malignant glioma (2967) 2967
brain cancer (2826) 2826
magnetic resonance imaging (2804) 2804
adolescent (2698) 2698
glioma - radiotherapy (2671) 2671
analysis (2617) 2617
child (2518) 2518
radiology, nuclear medicine & medical imaging (2475) 2475
brain (2458) 2458
brain neoplasms - therapy (2444) 2444
apoptosis (2441) 2441
neurology (2422) 2422
neurosciences (2380) 2380
glioma - drug therapy (2333) 2333
treatment outcome (2327) 2327
expression (2286) 2286
brain-tumors (2284) 2284
glioblastoma - pathology (2195) 2195
combined modality therapy (2143) 2143
radiation (2142) 2142
health aspects (2087) 2087
brain neoplasms - metabolism (2040) 2040
brain neoplasms - mortality (2036) 2036
mice (2002) 2002
radiation therapy (1977) 1977
brain neoplasms - genetics (1967) 1967
brain neoplasms - surgery (1962) 1962
radiation-therapy (1949) 1949
glioblastoma-multiforme (1886) 1886
retrospective studies (1866) 1866
malignant gliomas (1852) 1852
development and progression (1801) 1801
glioma - therapy (1714) 1714
glioma - metabolism (1697) 1697
therapy (1664) 1664
child, preschool (1644) 1644
glioblastoma - drug therapy (1600) 1600
glioma - genetics (1546) 1546
genetic aspects (1529) 1529
survival analysis (1492) 1492
medical prognosis (1486) 1486
dacarbazine - analogs & derivatives (1481) 1481
young adult (1479) 1479
gene expression (1468) 1468
cell biology (1465) 1465
proteins (1434) 1434
neurosurgery (1431) 1431
brain neoplasms - diagnosis (1394) 1394
patients (1383) 1383
children (1352) 1352
diagnosis (1330) 1330
medical research (1329) 1329
article (1300) 1300
survival rate (1282) 1282
pediatrics (1278) 1278
follow-up studies (1275) 1275
cancer therapies (1271) 1271
glioma - surgery (1251) 1251
medicine (1248) 1248
stem cells (1236) 1236
growth (1232) 1232
astrocytoma (1231) 1231
central-nervous-system (1227) 1227
glioblastoma - radiotherapy (1227) 1227
pathology (1216) 1216
adjuvant temozolomide (1195) 1195
glioma - mortality (1188) 1188
rats (1173) 1173
immunohistochemistry (1170) 1170
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (26114) 26114
Japanese (266) 266
French (263) 263
German (199) 199
Spanish (85) 85
Russian (50) 50
Chinese (41) 41
Polish (28) 28
Czech (24) 24
Italian (19) 19
Portuguese (13) 13
Hungarian (10) 10
Swedish (10) 10
Dutch (7) 7
Korean (7) 7
Danish (3) 3
Finnish (3) 3
Hebrew (3) 3
Turkish (3) 3
Croatian (2) 2
Latvian (1) 1
Norwegian (1) 1
Persian (1) 1
Romanian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. I. Cyberknife Stereotactic-Radiotherapy for Gliomas
by Tabei, Yusuke and Nomura, Ryutarou and Sato, Kengo and Karasawa, Katsuyuki and Ichi, Shunsuke
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 06/2018, Volume 45, Issue 6, p. 923
Humans | Radiosurgery - instrumentation | Radiosurgery - methods | Glioma - radiotherapy
Journal Article
Details down arrow
2. Full Text Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
by Stupp, Roger and Mason, Warren P and van den Bent, Martin J and Weller, Michael and Fisher, Barbara and Taphoorn, Martin J.B and Belanger, Karl and Brandes, Alba A and Marosi, Christine and Bogdahn, Ulrich and Curschmann, Jürgen and Janzer, Robert C and Ludwin, Samuel K and Gorlia, Thierry and Allgeier, Anouk and Lacombe, Denis and Cairncross, J. Gregory and Eisenhauer, Elizabeth and Mirimanoff, René O and European Org Res Treatment Canc Br and European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups and National Cancer Institute of Canada Clinical Trials Group
The New England Journal of Medicine, ISSN 0028-4793, 03/2005, Volume 352, Issue 10, pp. 987 - 996
Most patients with glioblastoma multiforme, the most common primary malignant brain tumor in adults, die within two years of the diagnosis, despite surgery and... 
MALIGNANT GLIOMA | MEDICINE, GENERAL & INTERNAL | POSTOPERATIVE TREATMENT | PROGNOSTIC-FACTORS | THERAPY-ONCOLOGY-GROUP | RANDOMIZED-TRIAL | PHASE-II | MULTIFORME | CHEMOTHERAPY | CARMUSTINE | RADIATION-THERAPY | Dacarbazine - adverse effects | Radiotherapy, Computer-Assisted - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Proportional Hazards Models | Male | Adrenal Cortex Hormones - therapeutic use | Brain Neoplasms - drug therapy | Glioblastoma - radiotherapy | Disease Progression | Antineoplastic Agents, Alkylating - therapeutic use | Dacarbazine - analogs & derivatives | Survival Analysis | Adult | Female | Aged | Brain Neoplasms - mortality | Chemotherapy, Adjuvant | Antineoplastic Agents, Alkylating - adverse effects | Brain Neoplasms - radiotherapy | Glioblastoma - drug therapy | Glioblastoma - mortality | Usage | Temozolomide | Research | Diagnosis | Radiotherapy | Health aspects | Glioblastoma multiforme | Clinical trials | Chemotherapy | Radiation therapy | Brain cancer | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
by Chinot, Olivier L and Wick, Wolfgang and Mason, Warren and Henriksson, Roger and Saran, Frank and Nishikawa, Ryo and Carpentier, Antoine F and Hoang-Xuan, Khe and Kavan, Petr and Cernea, Dana and Brandes, Alba A and Hilton, Magalie and Abrey, Lauren and Cloughesy, Timothy and Medicinska fakulteten and Institutionen för strålningsvetenskaper and Onkologi and Umeå universitet
The New England Journal of Medicine, ISSN 0028-4793, 02/2014, Volume 370, Issue 8, pp. 709 - 722
In patients with glioblastoma, the addition of bevacizumab to radiotherapy and temozolomide induction therapy and the use of bevacizumab maintenance therapy... 
CONCOMITANT RADIOCHEMOTHERAPY | MEDICINE, GENERAL & INTERNAL | PHASE-II TRIAL | RECURRENT GLIOBLASTOMA | CLINICAL-TRIALS | MALIGNANT GLIOMAS | QUALITY-OF-LIFE | RESPONSE ASSESSMENT CRITERIA | MULTIFORME | HIGH-GRADE GLIOMA | ENDOTHELIAL GROWTH-FACTOR | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Induction Chemotherapy | Male | Glioblastoma - radiotherapy | Bevacizumab | Young Adult | Dacarbazine - analogs & derivatives | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Brain Neoplasms - mortality | Brain Neoplasms - radiotherapy | Angiogenesis Inhibitors - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Kaplan-Meier Estimate | Combined Modality Therapy | Brain Neoplasms - drug therapy | Disease-Free Survival | Quality of Life | Aged | Glioblastoma - drug therapy | Glioblastoma - mortality | Dosage and administration | Research | Temozolomide | Drug therapy, Combination | Drug therapy | Glioblastoma multiforme | Nuclear magnetic resonance--NMR | Intravenous administration | Glucocorticoids | Brain cancer | Body weight | Glioblastoma | Radiation therapy | Survival | Patients | Quality of life | Vascular endothelial growth factor | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience
by Kamada, Tadashi, MD and Tsujii, Hirohiko, MD and Blakely, Eleanor A, PhD and Debus, Jürgen, Prof and De Neve, Wilfried, Prof and Durante, Marco, Prof and Jäkel, Oliver, Prof and Mayer, Ramona, Prof and Orecchia, Roberto, Prof and Pötter, Richard, Prof and Vatnitsky, Stanislav, PhD and Chu, William T, PhD
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. e93 - e100
Summary Charged particle therapy is generally regarded as cutting-edge technology in oncology. Many proton therapy centres are active in the USA, Europe, and... 
Hematology, Oncology and Palliative Medicine | PROTON-BEAM THERAPY | GLIOMAS | 2ND MALIGNANCIES | ONCOLOGY | LOCALIZED PROSTATE-CANCER | HEAVY CHARGED-PARTICLES | PHASE-I/II | PARTICLE RADIATION-THERAPY | PHOTON RADIATION | CERVICAL-CANCER | CHEMOTHERAPY | Neoplasms - radiotherapy | Carbon - therapeutic use | Heavy Ion Radiotherapy | Time Factors | Humans | Japan | Physicists | Sarcoma | Radiotherapy | Pancreatic cancer | X-rays | Colorectal cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Opportunities and challenges of radiotherapy for treating cancer
by Schaue, Dörthe and Mcbride, William H
Nature Reviews Clinical Oncology, ISSN 1759-4774, 09/2015, Volume 12, Issue 9, pp. 527 - 540
The past 20 years have seen dramatic changes in the delivery of radiation therapy, but the impact of radiobiology on the clinic has been far less substantial.... 
GROWTH-FACTOR RECEPTOR | POLY(ADP-RIBOSE) POLYMERASE | GAMMA-SECRETASE INHIBITOR | STRAND BREAK REPAIR | ONCOLOGY | CHECKPOINT KINASE CHK1 | DNA-DAMAGE RESPONSE | GLIOMA STEM-CELLS | HISTONE DEACETYLASE INHIBITORS | NF-KAPPA-B | RADIATION-THERAPY | Dose Fractionation | Neoplasms - radiotherapy | Radiotherapy - trends | Humans | Care and treatment | Radiotherapy | Health aspects | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Guidelines for the radiotherapy of gliomas
by Feuvret, L and Antoni, D and Biau, J and Truc, G and Noel, G and Mazeron, J.-J
Cancer / Radiotherapie, ISSN 1278-3218, 09/2016, Volume 20, p. S69-S79
Les gliomes sont les tumeurs cerebrales primitives de l'adulte les plus frequentes. Leur traitement est difficile en raison de la proximite des organes a... 
Gliomas | Radiotherapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Gold nanoparticle imaging and radiotherapy of brain tumors in mice
by Hainfeld, James F and Smilowitz, Henry M and O'connor, Michael J and Dilmanian, Farrokh Avraham and Slatkin, Daniel N
Nanomedicine, ISSN 1743-5889, 2013, Volume 8, Issue 10, pp. 1601 - 1609
Aim: To test intravenously injected gold nanoparticles for x-ray imaging and radiotherapy enhancement of large, imminently lethal, intracerebral malignant... 
dose enhancement | x-ray | gold nanoparticle | radiotherapy | brain tumor | glioma | cancer | microcomputed tomography | imaging | contrast agent | CELLS | NANOSCIENCE & NANOTECHNOLOGY | F98 GLIOMA | RADIATION-THERAPY | MALIGNANT GLIOMA | MONTE-CARLO | SYNCHROTRON STEREOTACTIC RADIOTHERAPY | GLIOBLASTOMA | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | IN-VIVO | Gold - administration & dosage | Brain Neoplasms - diagnostic imaging | Humans | Brain Neoplasms - pathology | Kaplan-Meier Estimate | Metal Nanoparticles - adverse effects | Tomography, X-Ray Computed | Radiation Dosage | Blood-Brain Barrier - drug effects | Glioma - radiotherapy | Animals | Glioma - diagnostic imaging | Metal Nanoparticles - administration & dosage | Glioma - pathology | Mice | Brain Neoplasms - radiotherapy | Gold - adverse effects
Journal Article
Details down arrow
8. Full Text Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
by Wick, Wolfgang, Prof and Platten, Michael, Prof and Meisner, Christoph, PhD and Felsberg, Jörg, MD and Tabatabai, Ghazaleh, MD and Simon, Matthias, MD and Nikkhah, Guido, Prof and Papsdorf, Kirsten, MD and Steinbach, Joachim P, Prof and Sabel, Michael, MD and Combs, Stephanie E, MD and Vesper, Jan, MD and Braun, Christian, MD and Meixensberger, Jürgen, Prof and Ketter, Ralf, MD and Mayer-Steinacker, Regine, MD and Reifenberger, Guido, Prof and Weller, Michael, Prof and German Canc Soc and NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German Cancer Society
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 7, pp. 707 - 715
Summary Background Radiotherapy is the standard care in elderly patients with malignant astrocytoma and the role of primary chemotherapy is poorly defined. We... 
Hematology, Oncology and Palliative Medicine | OLDER PATIENTS | ONCOLOGY | PROMOTER METHYLATION | NEWLY-DIAGNOSED GLIOBLASTOMA | CONCOMITANT | CLASSIFICATION | PATTERNS | MULTIFORME | CARE | ADJUVANT TEMOZOLOMIDE | Astrocytoma - radiotherapy | Promoter Regions, Genetic | Dacarbazine - therapeutic use | Humans | DNA Repair Enzymes - genetics | Isocitrate Dehydrogenase - genetics | Male | Brain Neoplasms - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Disease-Free Survival | DNA Methylation | DNA Modification Methylases - genetics | Tumor Suppressor Proteins - genetics | Astrocytoma - drug therapy | Dacarbazine - analogs & derivatives | Aged, 80 and over | Female | Aged | Brain Neoplasms - mortality | Brain Neoplasms - radiotherapy | Astrocytoma - mortality | Care and treatment | Oncology, Experimental | Radiation | Aged patients | Research | Antineoplastic agents | Radiotherapy | Biometry | Antimitotic agents | Chemotherapy | Nuclear radiation | Gliomas | Product development | Temozolomide | Cancer | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights